| NCT ID | NCT05248165 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Federico II University |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2022-03-01 |
| Primary Completion | 2032-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2022-03-01 with a primary completion date of 2032-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the Naples PCI registry is to collect prospective data on baseline clinical, laboratory, and angiographic characteristics of patients undergoing PCI for acute or chronic coronary artery disease. All patients receive clinical follow-up at hospital discharge and at 1-year follow-up with the objective to assess clinical outcomes, including death, cardiovascular death, myocardial infarction, stroke, stent thrombosis, target-lesion and target-vessel revascularization, contrast-induced acute kidney injury, and bleeding events.
Eligibility Criteria
Inclusion Criteria: 1. Clinical evidence of coronary artery disease requiring PCI; 2. Age ≥18 years; 3. Written informed consent. Exclusion Criteria: 1\. Inability to provide informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05248165 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05248165 currently recruiting?
Yes, NCT05248165 is actively recruiting participants. Contact the research team at espogiov@unina.it for enrollment information.
Where is the NCT05248165 trial being conducted?
This trial is being conducted at Naples, Italy.
Who is sponsoring the NCT05248165 clinical trial?
NCT05248165 is sponsored by Federico II University. The trial plans to enroll 5,000 participants.